The Oncology Institute, Inc. TOI Finance Lease Liability - Undiscounted Excess Amount
Finance Lease Liability - Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s finance lease liability - undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s finance lease liability - undiscounted excess amount?
- The Oncology Institute, Inc. (TOI) reported finance lease liability - undiscounted excess amount of $3K in Q1 2026.
- How has The Oncology Institute, Inc.'s finance lease liability - undiscounted excess amount changed year-over-year?
- The Oncology Institute, Inc.'s finance lease liability - undiscounted excess amount decreased by 57.1% year-over-year, from $7K to $3K.
- What does finance lease liability - undiscounted excess amount mean?
- This represents the total undiscounted future cash payments required for finance leases, excluding the recognized lease liability. It provides visibility into the long-term contractual obligations for leased assets that are not yet reflected as current debt. Monitoring this helps investors understand the full scale of off-balance sheet or future lease commitments.